Glycogen storage disease type IV: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Glycogenosis type IV; Andersen's disease; glycogen branching enzyme deficiency (GBED); polyglucosan body disease; amylopectinosis | {{SK}} Glycogenosis type IV; Andersen's disease; glycogen branching enzyme deficiency (GBED); polyglucosan body disease; amylopectinosis; glycogenosis type 4 | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. |
Revision as of 18:21, 20 September 2012
Glycogen storage disease type IV | ||
Glycogen | ||
ICD-10 | E74.0 | |
ICD-9 | 271.0 | |
OMIM | 232500 | |
DiseasesDB | 5303 | |
MeSH | C16.320.565.202.449.540 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Glycogenosis type IV; Andersen's disease; glycogen branching enzyme deficiency (GBED); polyglucosan body disease; amylopectinosis; glycogenosis type 4
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Glycogen storage disease type IV is a very rare hereditary metabolic disorder.
Pathophysiology
It is a result of the absence of the glycogen branching enzyme amylo-1,4-1,6 transglucosidase, which is critical in the production of glycogen. This leads to very long unbranched glucose chains being stored in glycogen. The long unbranched molecules (known as amylopectin) have a low solubility which leads to glycogen precipitation in the liver. These deposits subsequently build up in the body tissue, especially the heart and liver.
Complications and Prognosis
The end result is liver failure and eventual death occurring in the first year of life.